🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

7) A source familiar with the situation said that Sanders in March proposed three potential NIH directors to the White House: Aaron Kesselheim of Harvard Medical School, Vincent Rajkumar Vincent Rajkumar of Mayo Clinic, and Sarah Szanton, dean of the Johns Hopkins School of Nursing.

Very interesting work coming out of #ASCO2023. We can hear the sound of cancer cell dying!! Measured by Ramen spectroscopy!It truly is the most beautiful sound for our patients!! themostbeautifulsound.org Vincent Rajkumar Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Noopur Raje #themostbeautifulsound

The real impact of the most beautiful sound of cancer cell dying! #ASCO2023 Vincent Rajkumar Noopur Raje #CancerResearch #dfci

Dr. Luciano Costa presenting update of one of the most important and innovative IIT study demonstrating the role of MRD in determining treatment duration and the practical use of MRD. Luciano J Costa Myeloma Society International Myeloma Foundation #mmsm #EHA2023

Congratuations to Dr. Rajkumar for being appointed as Chairman-Elect of the Board of Directors of the International Myeloma Foundation. His leadership brings renewed hope, promising affordable access to new treatment while fostering continued development of innovative therapies.

Well deserved recognition for Dr. Rajkumar !! globenewswire.com/en/news-releas…

With today's approval of Pfizer’s ELREXFIO, we have now 5 new immunotherapies approved in last 2 years with responses between 60-98%. Incredible times!! And more to come. Vincent Rajkumar Noopur Raje @mmrf Myeloma Society #mmsm International Myeloma Foundation Multiple Myeloma RF @HealthtreeMM ASH

The #IMS23 countdown has nearly reached zero! 🚨 Don't miss out - register for the #Athens or #virtual event TODAY to join your colleagues! 🤩 With only days left, check out ow.ly/1aT850PPmHX to save your spot and find more information. #IMS23

Dr. Nikhil Munshi Nikhil C. Munshi, MD has transformed Myeloma Society in his 4-year term as President. A wonderful recognition today for Nikhil at #IMS23 #MedTwitter

Very important FDA-IMS workshop tomorrow to discuss future drug approval pathways in myeloma. Focus on drug approval process in newly diagnosed and relapsed MM. Join and participate. Still time to register. Vincent Rajkumar Sagar Lonial MD smmm Noopur Raje myelomasociety.org/events/fda-ims…

MRD as an official endpoint for accelerated approval ODAC votes 12-0 great work by all congratulations!!

Nikhil C. Munshi, MD Thx for all your pioneering papers in this Dr. Munshi

Getting MRD as an endpoint was a great partnership between academia and industry and patient organization. A model to follow. Patients are three winner. Vincent Rajkumar #@NoopurRajeMD #myelomasociety

A wonderful discussion revising the response criteria in myeloma at IMS/IMWG Workshop. Reflecting the great progress, now we are discussing definition of potential Cure !! Vincent Rajkumar Myeloma Society Shaji Kumar Sagar Lonial MD Shaji Kumar Noopur Raje Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰

An interesting paper in Blood by Dr. Samur suggesting that the cell that eventually becomes myeloma first acquires extra chromosome in 2nd decade of life and becomes fully hyperdiploid by 3rd. Implications for many cancers. doi.org/10.1182/blood.… Vincent Rajkumar ASCO ASH

Thrilled to have our first Myeloma Society educational meeting in Johannesburg with Nikhil C. Munshi, MD Shaji Kumar Meral Beksac .. beginning of a strong collaboration with the African continent fir #mmsm

Very important myeloma educational meeting for the first time in Africa organized by Noopur Raje. IMS serving educational needs globally #mmsm

It was a true honor to open #NBC2025 yesterday. My sincere thanks to @aapscomms for the opportunity to address such a distinguished group of leaders and innovators!

Major Regulatory Milestone in MM: In response to an application by I2TEAMM and International Myeloma Foundation, the European Medicines Agency has officially endorsed MRD as an early endpoint in clinical trials for Myeloma. This marks a transformative step forward in drug development !! Vincent Rajkumar

Excellent out-reach by IMS to expand education and develop global co-operation